Free Trial

MiMedx Group (MDXG) Earnings Date, Estimates & Call Transcripts

MiMedx Group logo
$9.14 +0.02 (+0.22%)
As of 04:00 PM Eastern

MiMedx Group Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 26After Market ClosesEstimated
Actual EPS
(Oct. 30)
$0.07 Beat By $0.02
Consensus EPS
(Oct. 30)
$0.05

MiMedx Group posted Q3 2024 earnings on October 30, 2024, reporting an EPS of $0.07, which topped analysts' consensus estimates of $0.05 by $0.02. Quarterly revenue was reported to be $84.06 million, above the consensus estimate of $81 million. With a trailing EPS of $0.55 and a P/E Ratio of 16.62, MiMedx Group's earnings are expected to remain at $0.30 per share in the coming year.

MDXG Upcoming Earnings

MiMedx Group's next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules.

Get MiMedx Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiMedx Group and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MDXG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MDXG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MiMedx Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251$0.05$0.05$0.05 
Q2 20251$0.08$0.08$0.08 
Q3 20251$0.08$0.08$0.08 
Q4 20251$0.09$0.09$0.09 
FY 20254$0.30$0.30 $0.30

MiMedx Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/26/2025
(Estimated)
-------
10/30/2024Q3 2024$0.05$0.07+$0.02$0.09$81.00M$84.06M
7/31/2024Q2 2024$0.08$0.08-$0.04$88.44M$87.21M
4/30/2024Q1 2024$0.04$0.07+$0.03$0.08$79.36M$84.71M
2/28/2024Q4 2023$0.08$0.04 -$0.04-$0.24$85.58M$86.83M
10/30/2023Q3 2023$0.04$0.05+$0.01$0.04$76.69M$81.71M
5/2/2023Q1 2023-$0.09-$0.06+$0.03-$0.06$63.48M$71.68M
2/28/2023Q4 2022-$0.02-$0.02--$0.02$74.31M$74.38M

MiMedx Group Earnings - Frequently Asked Questions

MiMedx Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on MDXG's earnings history.

MiMedx Group (NASDAQ:MDXG) has a recorded annual revenue of $321.48 million.

MiMedx Group (NASDAQ:MDXG) has a recorded net income of $58.23 million. MDXG has generated $0.55 earnings per share over the last four quarters.

MiMedx Group (NASDAQ:MDXG) has a trailing price-to-earnings ratio of 16.62 and a forward price-to-earnings ratio of 30.47.

MiMedx Group's earnings are expected to stay at $0.30 per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:MDXG) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners